Learn about our healthcare areas

Explore medicine and therapy products
Explore MedTech products

Find our latest news, stories and press releases

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

Search Results

No Results

    Recently Viewed

      Listening...

      Sorry, I don't understand. Please try again
      1. Home/
      2. News/
      3. Innovation/
      4. Innovation-opedia: What is a mosaic vaccine?
      Graphic featuring a syringe to illustrate an HIV vaccine trial
      Innovation

      Innovation-opedia: What is a mosaic vaccine?

      As the IAS Conference on HIV Science kicks off in Mexico City, we explain how an investigational HIV vaccine from the Janssen Pharmaceutical Companies of Johnson & Johnson works—and how researchers hope to help change lives around the world with it.

      Written by Johnson & Johnson
       | July 22, 2019
      July 22, 2019
      Illustrated handwritten definition of a mosaic HIV vaccine
      Illustration of a microscope with information about Janssen Vaccines & Prevention B.V. investigational HIV-1 vaccine regimen
      Inset- Innovation-opedia: What Is a Mosaic Vaccine?- mosaic-vaccine-4-immunizations_above
      Illustration of the # 4 explaining how many injections would be administered for Janssen’s investigational HIV-1 vaccine.
      Inset- Innovation-opedia: What Is a Mosaic Vaccine?- mosaic-vaccine-4-immunizations_below
      Illustration showing location of the IAS Conference on HIV Science with details about Janssen’s new Mosaico clinical trial.
      Illustrated quote by Janssen’s Maria Grazia Pau talking about the goal of creating a global HIV vaccine.

      We’re committed to helping lead the fight against HIV/AIDS

      Read about the many ways Johnson & Johnson is working to #makeHIVhistory.
      Learn more
      CTA-Red ribbon HIV

      HIV vaccine J&J Innovative Medicine Johnson & Johnson

      More from Johnson & Johnson

      Latest news
      July 16, 2025

      What you need to know about Johnson & Johnson’s 2025 second-quarter earnings

      Here’s an infographic breakdown of the company’s second-quarter earnings results, including key highlights from its Innovative Medicine and MedTech businesses.
      Read more
      Innovation
      June 25, 2025

      Introducing the first and only daily disposable multifocal contact lens for people with astigmatism

      A Johnson & Johnson scientist explains how the new Acuvue® Oasys Max 1-Day Multifocal for Astigmatism contact lens also filters blue light, supports the eye’s natural tear film and helps eyes easily switch focus from distance to reading.
      Read more
      Health & wellness
      June 12, 2025

      What is wAIHA?

      Warm autoimmune hemolytic anemia (wAIHA) causes fatigue so profound, it can limit the lives of people who have the condition. Learn more about this rare disease and a potential targeted treatment developed by Johnson & Johnson that’s currently in clinical trials.
      Read more